Vertex Expects Shorter Duration Of Therapy Will Give Telaprevir Long Reign Atop Market
With high SVR rate and quad therapy showing potential for 12-week treatment period, telaprevir may enjoy short- and long-term market success.
With high SVR rate and quad therapy showing potential for 12-week treatment period, telaprevir may enjoy short- and long-term market success.